Form 424B2 - Prospectus [Rule 424(b)(2)]:
SEC Accession No. 0001193125-25-183493
Filing Date
2025-08-19
Accepted
2025-08-19 17:17:32
Documents
15

Document Format Files

Seq Description Document Type Size
1 424B2 d70052d424b2.htm 424B2 530201
2 EX-FILING FEES d70052dexfilingfees.htm   iXBRL EX-FILING FEES 36988
3 GRAPHIC g70052g01a33.jpg GRAPHIC 37747
4 GRAPHIC g70052g01d66.jpg GRAPHIC 36978
5 GRAPHIC g70052g01p14.jpg GRAPHIC 30218
  Complete submission text file 0001193125-25-183493.txt   867634

Data Files

Seq Description Document Type Size
18 EXTRACTED XBRL INSTANCE DOCUMENT d70052dexfilingfees_htm.xml XML 15888
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Filer) CIK: 0000059478 (see all company filings)

EIN.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: 424B2 | Act: 33 | File No.: 333-285052 | Film No.: 251232918
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)